Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group
Authors:
Top Cited Papers
- 14 September 2022
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 167 (2) , 373-389
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Embryonal Rhabdomyosarcoma (Botryoid Type) of the Uterine Corpus and Cervix in Adult WomenAmerican Journal of Surgical Pathology, 2013
- The Clinicopathologic Features of YWHAE-FAM22 Endometrial Stromal SarcomasAmerican Journal of Surgical Pathology, 2012
- Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regionsAnnals of Oncology, 2012
- 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcomaProceedings of the National Academy of Sciences, 2012
- Epithelioid Inflammatory Myofibroblastic SarcomaAmerican Journal of Surgical Pathology, 2011
- Crizotinib inALK-Rearranged Inflammatory Myofibroblastic TumorNew England Journal of Medicine, 2010
- TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET InhibitionCancer Research, 2007
- Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989–1999Gynecologic Oncology, 2004
- The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitinationOncogene, 2000
- Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcomaCancer, 2000